Tegaserod maleate is currently used to treat irritable bowel syndrome, but has also been shown to have an inhibitory effect on the growth of breast cancer xenografts in mice when used in combination with anti-PD1/anti-TIGIT (immunotherapy)45,46. The gene discussed is TIGIT; the disease is breast carcinoma.